1,432
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

HOTAIR knockdown impairs metastasis of cervical cancer cells by down-regulating metastasis-related genes

, , , , , & show all
Article: 2181060 | Received 18 Apr 2022, Accepted 10 Feb 2023, Published online: 27 Mar 2023

References

  • Battaglia, R.A., et al. 2018. Vimentin on the move: new developments in cell migration. F1000Research, 7, 1796.
  • Berteaux, N., et al. 2005. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. The Journal of Biological Chemistry, 280 (33), 29625–29636.
  • Cai, L., et al. 2017. The lncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma. Journal of Cellular and Molecular Medicine, 21 (11), 2654–2662.
  • Caley, D.P., et al. 2010. Long noncoding RNAs, chromatin, and development. The Scientific World Journal, 10, 90–102.
  • Cancer Genome Atlas Research, et al. 2017. Integrated genomic and molecular characterization of cervical cancer. Nature, 543, 378–384.
  • Chao, Y.L., Shepard, C.R. and Wells, A., 2010. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Molecular Cancer, 9 (1), 179.
  • Chen, F.J., et al. 2013. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Molecular Carcinogenesis, 52 (11), 908–915.
  • de Wit, S., et al. 2018. EpCAM(high) and EpCAM(low) circulating tumor cells in metastatic prostate and breast cancer patients. Oncotarget, 9 (86), 35705–35716.
  • Garcia-Gimenez, J.L., et al. 2017. Role of glutathione in the regulation of epigenetic mechanisms in disease. Free Radical Biology and Medicine, 112, 36–48.
  • Guilford, P., 1999. E-cadherin downregulation in cancer: fuel on the fire? Molecular Medicine Today, 5 (4), 172–177.
  • Gupta, R.A., et al. 2010. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 464 (7291), 1071–1076.
  • Hajjari, M. and Salavaty, A., 2015. HOTAIR: an oncogenic long non-coding RNA in different cancers. Cancer Biology & Medicine, 12 (1), 1–9.
  • Howard, E.W., et al. 2008. E-cadherin upregulation as a therapeutic goal in cancer treatment. Mini Reviews in Medicinal Chemistry, 8 (5), 496–518.
  • Ji, F., et al. 2018. Long noncoding RNA HOTAIR: an oncogene in human cervical cancer interacting with microRNA-17-5p. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 26 (3), 353–361.
  • Kodama, J., et al. 2010. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy. Journal of Surgical Oncology, 101 (5), 413–417.
  • Li, C., et al. 2018. Upregulation of Ecadherin expression mediated by a novel dsRNA suppresses the growth and metastasis of bladder cancer cells by inhibiting beta-catenin/TCF target genes. International Journal of Oncology., 52, 1815–1826.
  • Li, L., et al. 2017. Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy. Medical Oncology, 34 (10), 180.
  • Lin, J., et al. 2017. The prognostic values of the expression of Vimentin, TP53, and Podoplanin in patients with cervical cancer. Cancer Cell International, 17 (1), 80.
  • Liu, M., et al. 2018. Long non-coding RNA HOTAIR promotes cervical cancer progression through regulating BCL2 via targeting miR-143-3p. Cancer Biology & Therapy, 19 (5), 391–399.
  • Liu, S., Zhang, M. and Qu, P., 2016. Expression level and clinical significance of HOX transcript antisense intergenic RNA in cervical cancer: a meta-analysis. Scientific Reports, 6, 38047.
  • Liu, Z., et al. 2020. GATA1-regulated JAG1 promotes ovarian cancer progression by activating Notch signal pathway. Protoplasma, 257 (3), 901–910.
  • Livak, K.J. and Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25 (4), 402–408.
  • Loewen, G., et al. 2014. Functions of lncRNA HOTAIR in lung cancer. Journal of Hematology & Oncology, 7, 90.
  • Menderes, G., et al. 2016. Immunotherapy and targeted therapy for cervical cancer: an update. Expert Review of Anticancer Therapy, 16 (1), 83–98.
  • Morgan, E.L. and Macdonald, A., 2019a. Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NFkappaB-IL-6 signalling axis. PLOS Pathogens, 15 (6), e1007835.
  • Morgan, E.L. and Macdonald, A., 2019b. JAK2 inhibition impairs proliferation and sensitises cervical cancer cells to cisplatin-induced cell death. Cancers, 11 (12), 1934.
  • Morgan, E.L., et al. 2018. STAT3 activation by E6 is essential for the differentiation-dependent HPV18 life cycle. PLoS Pathogens, 14 (4), e1006975.
  • Osta, W.A., et al. 2004. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Research, 64 (16), 5818–5824.
  • Park, D.J., et al. 2020. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1. Journal for ImmunoTherapy of Cancer, 8 (1), e000301.
  • Pijuan, J., et al. 2019. In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis. Frontiers in Cell and Developmental Biology, 7, 107.
  • Rinn, J.L., et al. 2007. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell, 129 (7), 1311–1323.
  • Satelli, A. and Li, S., 2011. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cellular and Molecular Life Sciences, 68 (18), 3033–3046.
  • Shan, D., Shang, Y. and Hu, T., 2019. MicroRNA-411 inhibits cervical cancer progression by directly targeting STAT3. Oncology Research, 27 (3), 349–358.
  • Stoecklein, N.H., et al. 2006. Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker. BMC Cancer, 6, 165.
  • Subramanian, N., et al. 2015. EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex. Journal of Biomedical Science, 22, 4.
  • Tang, Q. and Hann, S.S., 2018. HOTAIR: an oncogenic long non-coding rna in human cancer. Cellular Physiology and Biochemistry, 47 (3), 893–913.
  • Torre, L.A., et al. 2015. Global cancer statistics, 2012. CA: a Cancer Journal for Clinicians, 65 (2), 87–108.
  • Vu, M., et al. 2018. Cervical cancer worldwide. Current Problems in Cancer, 42 (5), 457–465.
  • Wang, X., Yang, Y. and Huycke, M.M., 2017. Microbiome-driven carcinogenesis in colorectal cancer: Models and mechanisms. Free Radical Biology and Medicine, 105, 3–15.
  • Wells, A., Yates, C. and Shepard, C.R., 2008. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clinical & Experimental Metastasis, 25 (6), 621–628.
  • Wenqi, D., et al. 2009. EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer. Journal of Cancer Research and Clinical Oncology, 135 (9), 1277–1285.
  • Xu, Z., et al. 2017. URI promotes the migration and invasion of human cervical cancer cells potentially via upregulation of vimentin expression. Am J Transl Res, 9, 3037–3047.
  • Yang, Z., et al. 2011. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Annals of Surgical Oncology, 18 (5), 1243–1250.
  • Zeng, Y.T., et al. 2019. REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer. Oncogene, 38 (43), 6940–6957.
  • Zhao, W., et al. 2018. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Medicine, 7 (3), 842–855.
  • Zhu, L. and Xu, P.C., 2013. Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression. Biochemical and Biophysical Research Communications, 432 (4), 612–617.